2023
Rhinoviruses
Landry M, Lu X. Rhinoviruses. 2023, 1-15. DOI: 10.1002/9781683674849.mcm0092.Peer-Reviewed Original ResearchRV isolatesDevelopment of clinical symptomsLower respiratory tract diseaseMediators of inflammationChemical mediators of inflammationReverse transcription polymerase chain reactionTranscription polymerase chain reactionRV infectionType-specific antiseraClinical symptomsPolymerase chain reactionPresumptive diagnosisRespiratory tract diseaseMolecular typingGold standardIncreased susceptibilityPredominant siteCell linesCytopathic effectChain reactionInadequate sleepViral diagnosticsCell culturesSerotypesSymptoms
1996
Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation.
Zhu Z, Tang W, Ray A, Wu Y, Einarsson O, Landry ML, Gwaltney J, Elias JA. Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. Journal Of Clinical Investigation 1996, 97: 421-430. PMID: 8567963, PMCID: PMC507033, DOI: 10.1172/jci118431.Peer-Reviewed Original ResearchConceptsIL-6 productionIL-6RV infectionPotent stimulatorIL-6 protein productionIL-6 siteSymptomatic RV infectionsNuclear factor kappa BFactor kappa BIL-6 mRNA accumulationNF-kappa B activationNF-kappa B DNA binding activityPromoter-driven luciferase activityRhinovirus stimulationRV challengeNF-kappa BNF-kappa B siteInterleukin-6Nasal washingsKappa BSymptomatic volunteersRhinovirusStimulation pathwayNuclear factorB activation